Aims and Scope of Oncology Reports
Oncology Reports is a peer-reviewed medical journal of oncology published monthly by Spandidos Publications. The editor-in-chief is Demetrios A. Spandidos. The journal was established in 1994.
Key Metrics
CiteScore 

7.6
Eigenfactor 

0.01 - 0.05
H-Index 

108
Impact Factor 

< 5
SJR 

Q2Oncology

SNIP 

0.79
Recommended pre-submission checks
Powered by 

Topics Covered on Oncology Reports
Oncology Reports Journal Specifications
| Overview | |
| Publisher | SPANDIDOS PUBL LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1994 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Oncology Reports ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Oncology Reports
Cancer signaling networks in tumor progression and drug resistance: Crosstalk, adaptive reprogramming and therapeutic targeting (Review).
- 1 Jul 2026
- Oncology reports
Combination of ivermectin and metformin promotes autophagy in MCF‑7 cells by inhibiting phosphorylation of the PI3K/AKT/mTOR pathway.
- 1 Jul 2026
- Oncology reports
SRRT promotes prostate cancer progression and serves as a prognostic biomarker through STAT3 pathway activation.
- 1 Jul 2026
- Oncology reports
Retracted] PTEN enhances G2/M arrest in etoposide‑treated MCF‑7 cells through activation of the ATM pathway.
- 1 Jul 2026
- Oncology reports
A novel regulatory role of microRNA‑5590‑3p in hepatocellular carcinoma via the HOXB2/MYC axis.
- 1 Jul 2026
- Oncology reports
Corrigendum] ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune micro-environment.
- 1 Jul 2026
- Oncology reports
Cancer signaling networks in tumor progression and drug resistance: Crosstalk, adaptive reprogramming and therapeutic targeting (Review).
- 1 Jul 2026
- Oncology reports
Combination of ivermectin and metformin promotes autophagy in MCF‑7 cells by inhibiting phosphorylation of the PI3K/AKT/mTOR pathway.
- 1 Jul 2026
- Oncology reports
SRRT promotes prostate cancer progression and serves as a prognostic biomarker through STAT3 pathway activation.
- 1 Jul 2026
- Oncology reports
Retracted] PTEN enhances G2/M arrest in etoposide‑treated MCF‑7 cells through activation of the ATM pathway.
- 1 Jul 2026
- Oncology reports
A novel regulatory role of microRNA‑5590‑3p in hepatocellular carcinoma via the HOXB2/MYC axis.
- 1 Jul 2026
- Oncology reports
Corrigendum] ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune micro-environment.
- 1 Jul 2026
- Oncology reports